Literature DB >> 8457605

Phagocytosis of P. falciparum malarial pigment hemozoin by human monocytes inactivates monocyte protein kinase C.

E Schwarzer1, F Turrini, G Giribaldi, M Cappadoro, P Arese.   

Abstract

Hemozoin (malarial pigment) is a ferriprotoporphyrin IX-rich hemoglobin degradation product present in parasitized RBC. Avidly phagocytosed hemozoin abolishes phagocyte TPA-induced oxidative burst. Membrane-associated PKC increased transiently in hemozoin-fed monocytes by 50% after 30 min and decreased irreversibly to 20% of initial value within 5 h after phagocytosis. Control RBC-fed monocytes showed transient decay of membrane-associated PKC followed by complete recovery 12 h after phagocytosis. Cytosolic PKC was not impaired within 12 h and diminished drastically 24 h after phagocytosis of hemozoin. Results are compatible with increased degradation of membrane-translocated PKC, possibly by iron/H2O2-mediated damage of cysteine-rich regulatory domains of PKC.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8457605     DOI: 10.1016/0925-4439(93)90089-j

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  18 in total

1.  Phagocytosis of the malarial pigment, hemozoin, impairs expression of major histocompatibility complex class II antigen, CD54, and CD11c in human monocytes.

Authors:  E Schwarzer; M Alessio; D Ulliers; P Arese
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

2.  Reduced peripheral PGE2 biosynthesis in Plasmodium falciparum malaria occurs through hemozoin-induced suppression of blood mononuclear cell cyclooxygenase-2 gene expression via an interleukin-10-independent mechanism.

Authors:  Christopher C Keller; James B Hittner; Benjamin K Nti; J Brice Weinberg; Peter G Kremsner; Douglas J Perkins
Journal:  Mol Med       Date:  2004 Jan-Jun       Impact factor: 6.354

3.  Group B streptococci persist inside macrophages.

Authors:  P Cornacchione; L Scaringi; K Fettucciari; E Rosati; R Sabatini; G Orefici; C von Hunolstein; A Modesti; A Modica; F Minelli; P Marconi
Journal:  Immunology       Date:  1998-01       Impact factor: 7.397

4.  The basis of the immunomodulatory activity of malaria pigment (hemozoin).

Authors:  Clare K Carney; Alexandra C Schrimpe; Kristin Halfpenny; Reese S Harry; Crystal M Miller; Malgorzata Broncel; Sarah L Sewell; Jacob E Schaff; Ravinder Deol; Melissa D Carter; David W Wright
Journal:  J Biol Inorg Chem       Date:  2006-07-26       Impact factor: 3.358

Review 5.  The impact of metal availability on immune function during infection.

Authors:  Andrew J Monteith; Eric P Skaar
Journal:  Trends Endocrinol Metab       Date:  2021-09-03       Impact factor: 12.015

6.  Reduced CD3/TCR complex expression leads to immunosuppression during Plasmodium falciparum malaria.

Authors:  Yvonne Kalmbach; Angelica B W Boldt; Benjamin Mordmüller; Maryvonne Kombila; Martin P Grobusch; Peter G Kremsner; Jürgen F J Kun
Journal:  Parasitol Res       Date:  2008-10-31       Impact factor: 2.289

7.  Induction of nitric oxide synthase and activation of signaling proteins in Anopheles mosquitoes by the malaria pigment, hemozoin.

Authors:  Leyla Akman-Anderson; Martin Olivier; Shirley Luckhart
Journal:  Infect Immun       Date:  2007-05-25       Impact factor: 3.441

8.  Purified malaria pigment (hemozoin) enhances dendritic cell maturation and modulates the isotype of antibodies induced by a DNA vaccine.

Authors:  Cevayir Coban; Ken J Ishii; David J Sullivan; Nirbhay Kumar
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

9.  Matrix Metalloproteinase-9 and Haemozoin: Wedding Rings for Human Host and Plasmodium falciparum Parasite in Complicated Malaria.

Authors:  Mauro Prato; Giuliana Giribaldi
Journal:  J Trop Med       Date:  2011-05-26

Review 10.  Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function.

Authors:  Owain R Millington; Caterina Di Lorenzo; R Stephen Phillips; Paul Garside; James M Brewer
Journal:  J Biol       Date:  2006-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.